Welcome to our dedicated page for Brightspring Health Services SEC filings (Ticker: BTSGU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Brightspring Health Services's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Brightspring Health Services's regulatory disclosures and financial reporting.
BrightSpring Health Services, Inc. executive Scott A. Greenwell, President of PharMerica, reported equity compensation awards on common stock and stock options. He acquired stock options for 49,073 shares at an exercise price of $0.00 per share and 20,020 shares of common stock as a grant.
According to the footnotes, the 20,020-share common stock award consists of restricted stock units that vest in three equal annual installments beginning on January 25, 2027. The 49,073 stock options also vest in three equal annual installments starting on that same date, aligning his compensation with long-term company performance.
BrightSpring Health Services, Inc. executive Scott A. Greenwell, President of PharMerica, reported equity compensation awards on common stock and stock options. He acquired stock options for 49,073 shares at an exercise price of $0.00 per share and 20,020 shares of common stock as a grant.
According to the footnotes, the 20,020-share common stock award consists of restricted stock units that vest in three equal annual installments beginning on January 25, 2027. The 49,073 stock options also vest in three equal annual installments starting on that same date, aligning his compensation with long-term company performance.
BrightSpring Health Services officer Lisa A. Nalley reported several equity transactions. On March 4, 2026, she exercised stock options for 30,000 shares of common stock at $6.37 per share and sold 30,000 shares in a registered public offering at $41.15 per share.
That day also reflected vesting of previously granted performance-based stock options from 2019 and 2020, which became fully vested after performance conditions were satisfied. On March 5, 2026, she received 21,354 restricted stock units and 52,344 stock options, generally vesting in three equal annual installments beginning January 25, 2027.
BrightSpring Health Services officer Lisa A. Nalley reported several equity transactions. On March 4, 2026, she exercised stock options for 30,000 shares of common stock at $6.37 per share and sold 30,000 shares in a registered public offering at $41.15 per share.
That day also reflected vesting of previously granted performance-based stock options from 2019 and 2020, which became fully vested after performance conditions were satisfied. On March 5, 2026, she received 21,354 restricted stock units and 52,344 stock options, generally vesting in three equal annual installments beginning January 25, 2027.
BrightSpring Health Services director and officer Jon B. Rousseau reported a mix of equity grants, option activity, and share sales. On March 4, 2026, he exercised 220,000 stock options at $6.37 per share and sold 220,000 common shares at $41.15 per share in a registered public offering.
On March 4–5, 2026, he was awarded several blocks of stock options and restricted stock units (RSUs), including 458,008 options, 955,823 options, and 186,845 RSUs. Some options are fully vested, while others and the RSUs vest in twelve equal quarterly installments starting April 25, 2026. After these transactions, he directly owned about 1,023,880 common shares, plus additional option and share interests held indirectly through family trusts, for which he disclaims beneficial ownership beyond his economic interest.
BrightSpring Health Services director and officer Jon B. Rousseau reported a mix of equity grants, option activity, and share sales. On March 4, 2026, he exercised 220,000 stock options at $6.37 per share and sold 220,000 common shares at $41.15 per share in a registered public offering.
On March 4–5, 2026, he was awarded several blocks of stock options and restricted stock units (RSUs), including 458,008 options, 955,823 options, and 186,845 RSUs. Some options are fully vested, while others and the RSUs vest in twelve equal quarterly installments starting April 25, 2026. After these transactions, he directly owned about 1,023,880 common shares, plus additional option and share interests held indirectly through family trusts, for which he disclaims beneficial ownership beyond his economic interest.
BrightSpring Health Services Chief Financial Officer Jennifer A. Phipps reported multiple equity transactions. She sold 35,000 shares of common stock at $41.15 per share in a registered public offering that closed on March 4, 2026, while exercising 35,000 stock options at $6.37 per share.
She also acquired several equity awards. On March 5, 2026, she received 53,384 restricted stock units that vest in three equal annual installments beginning on January 25, 2027. Performance-based stock options granted in 2019 and 2020 vested after performance conditions were satisfied, and additional options vest over three years starting January 25, 2027. Following these transactions, she directly owned 196,840 shares of common stock and 130,860 stock options.
BrightSpring Health Services Chief Financial Officer Jennifer A. Phipps reported multiple equity transactions. She sold 35,000 shares of common stock at $41.15 per share in a registered public offering that closed on March 4, 2026, while exercising 35,000 stock options at $6.37 per share.
She also acquired several equity awards. On March 5, 2026, she received 53,384 restricted stock units that vest in three equal annual installments beginning on January 25, 2027. Performance-based stock options granted in 2019 and 2020 vested after performance conditions were satisfied, and additional options vest over three years starting January 25, 2027. Following these transactions, she directly owned 196,840 shares of common stock and 130,860 stock options.
BrightSpring Health Services major shareholder entities associated with KKR reported several transactions in the company’s common stock. An affiliated holder, KKR Phoenix Aggregator L.P., sold 19,715,000 shares in an underwritten public offering at a net price of $40.961 per share. After these transactions, affiliated entities reported holding 41,824,259 shares of common stock. Additional movements included in-kind distributions that allowed ultimate recipients to make charitable donations of shares, with Messrs. Henry R. Kravis and George R. Roberts each donating shares they received. The reporting persons collectively disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest.
BrightSpring Health Services major shareholder entities associated with KKR reported several transactions in the company’s common stock. An affiliated holder, KKR Phoenix Aggregator L.P., sold 19,715,000 shares in an underwritten public offering at a net price of $40.961 per share. After these transactions, affiliated entities reported holding 41,824,259 shares of common stock. Additional movements included in-kind distributions that allowed ultimate recipients to make charitable donations of shares, with Messrs. Henry R. Kravis and George R. Roberts each donating shares they received. The reporting persons collectively disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest.
KKR-affiliated entities reported several transactions in BrightSpring Health Services common stock. The main move was an open-market sale of 19,715,000 shares at a net price of $40.961 per share through an underwritten public offering, leaving tens of millions of shares still indirectly held.
Additional entries cover 402,773 shares reclassified in connection with this sale, plus two bona fide gifts of 49,295 and 31,918 shares. Footnotes explain that these shares were distributed in kind to partners and shareholders so that ultimate recipients, including Messrs. Henry R. Kravis and George R. Roberts, could donate shares to charity. The reporting entities collectively disclaim beneficial ownership beyond any pecuniary interest.
KKR-affiliated entities reported several transactions in BrightSpring Health Services common stock. The main move was an open-market sale of 19,715,000 shares at a net price of $40.961 per share through an underwritten public offering, leaving tens of millions of shares still indirectly held.
Additional entries cover 402,773 shares reclassified in connection with this sale, plus two bona fide gifts of 49,295 and 31,918 shares. Footnotes explain that these shares were distributed in kind to partners and shareholders so that ultimate recipients, including Messrs. Henry R. Kravis and George R. Roberts, could donate shares to charity. The reporting entities collectively disclaim beneficial ownership beyond any pecuniary interest.
BrightSpring Health Services' major shareholder KKR Phoenix Aggregator L.P. has sold part of its stake through a large secondary offering. On March 2, 2026, selling stockholders agreed to sell 20,000,000 shares of common stock, including 19,715,000 shares from KKR Phoenix Aggregator L.P., to an underwriter at a net price of $40.961 per share, with the deal closing on March 4, 2026. After the transaction, KKR Phoenix Aggregator L.P. directly holds 41,824,259 shares, and KKR-affiliated entities and founders Henry R. Kravis and George R. Roberts may be deemed to beneficially own up to 41,938,202 shares, representing about 21.8% of BrightSpring’s 192,369,354 shares outstanding as of the offering’s closing. KKR Phoenix Aggregator L.P. entered a lock-up agreement restricting most additional sales of BrightSpring stock for 60 days from March 2, 2026, unless the underwriter consents.
BrightSpring Health Services' major shareholder KKR Phoenix Aggregator L.P. has sold part of its stake through a large secondary offering. On March 2, 2026, selling stockholders agreed to sell 20,000,000 shares of common stock, including 19,715,000 shares from KKR Phoenix Aggregator L.P., to an underwriter at a net price of $40.961 per share, with the deal closing on March 4, 2026. After the transaction, KKR Phoenix Aggregator L.P. directly holds 41,824,259 shares, and KKR-affiliated entities and founders Henry R. Kravis and George R. Roberts may be deemed to beneficially own up to 41,938,202 shares, representing about 21.8% of BrightSpring’s 192,369,354 shares outstanding as of the offering’s closing. KKR Phoenix Aggregator L.P. entered a lock-up agreement restricting most additional sales of BrightSpring stock for 60 days from March 2, 2026, unless the underwriter consents.
BrightSpring Health Services entered an underwriting agreement for an underwritten secondary offering of 20,000,000 shares of common stock at $41.15 per share. All of these shares were sold by KKR and management selling stockholders, so BrightSpring itself did not receive the sale proceeds, other than cash from related stock option exercises.
As part of the same transaction, BrightSpring repurchased 1,464,807 shares of its common stock from the underwriter. The underwriter did not receive underwriting fees on the repurchased shares. The deal was conducted under an automatic shelf registration on Form S-3ASR, with customary representations, covenants, and indemnification provisions.
BrightSpring Health Services entered an underwriting agreement for an underwritten secondary offering of 20,000,000 shares of common stock at $41.15 per share. All of these shares were sold by KKR and management selling stockholders, so BrightSpring itself did not receive the sale proceeds, other than cash from related stock option exercises.
As part of the same transaction, BrightSpring repurchased 1,464,807 shares of its common stock from the underwriter. The underwriter did not receive underwriting fees on the repurchased shares. The deal was conducted under an automatic shelf registration on Form S-3ASR, with customary representations, covenants, and indemnification provisions.
BrightSpring Health Services filed its annual report describing a nationwide platform delivering home and community-based pharmacy and provider services to complex Senior and Specialty patients. The company serves over 465,000 patients daily through about 10,500 clinical providers and pharmacists across all 50 states.
BrightSpring is reorganizing its portfolio by agreeing to divest its Community Living business for $835 million, treating it as discontinued operations and sharpening focus on home health, hospice, rehab, primary care, and integrated pharmacy. The report notes substantial indebtedness of approximately $2.6 billion and a highly competitive, heavily regulated reimbursement environment.
BrightSpring Health Services filed its annual report describing a nationwide platform delivering home and community-based pharmacy and provider services to complex Senior and Specialty patients. The company serves over 465,000 patients daily through about 10,500 clinical providers and pharmacists across all 50 states.
BrightSpring is reorganizing its portfolio by agreeing to divest its Community Living business for $835 million, treating it as discontinued operations and sharpening focus on home health, hospice, rehab, primary care, and integrated pharmacy. The report notes substantial indebtedness of approximately $2.6 billion and a highly competitive, heavily regulated reimbursement environment.
BrightSpring Health Services Chairman, President and Chief Executive Officer Jon B. Rousseau reported a tax-related share withholding. On January 25, 2026, BrightSpring withheld 49,304 shares of common stock at $39.64 per share to cover taxes on the vesting of 109,442 restricted stock units.
After this transaction, Rousseau directly owned 1,023,880 shares of BrightSpring common stock. He also had an indirect interest in 369,763 shares held by the Rousseau Family Trust, and he disclaims beneficial ownership of those indirect shares beyond his pecuniary interest.
BrightSpring Health Services Chairman, President and Chief Executive Officer Jon B. Rousseau reported a tax-related share withholding. On January 25, 2026, BrightSpring withheld 49,304 shares of common stock at $39.64 per share to cover taxes on the vesting of 109,442 restricted stock units.
After this transaction, Rousseau directly owned 1,023,880 shares of BrightSpring common stock. He also had an indirect interest in 369,763 shares held by the Rousseau Family Trust, and he disclaims beneficial ownership of those indirect shares beyond his pecuniary interest.